Dose of tinzaparin or dalteparin

DRUG2 trials

Sponsors

Karolinska Institutet

Conditions

BleedingCovid-19Covid19Thromboembolic EventsThromboembolism

Unknown Phase

Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients

CompletedNCT04412304

Karolinska InstitutetBleeding, Covid-19, Thromboembolic Events

Start: 2020-03-06End: 2020-05-28Updated: 2020-06-22

Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients

CompletedNCT04593654

Karolinska InstitutetCovid19, Thromboembolism

Start: 2020-03-01End: 2020-10-15Updated: 2023-05-31

Related Papers

Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients.

2020-11-2365 citations